Although the expressional regulation of its target genes such as DNMT1, DNMT3A and DNMT3B has been reported in breast cancer cells [35], one of its notable underlying mechanisms for the progression of malignancy is its binding with its target proteins and regulation of their activity. This evidence concerns the gene DNMT3A and breast cancer.